Skip to main content

Grey Michael G's Form 4 filing

Mirum Pharmaceuticals, Inc. (MIRM) · filed Sep 14, 2023

Accession no.
0001209191-23-049511
Filed
Sep 14, 2023
Trade date
Sep 13-14, 2023
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $467.5K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Grey Michael GCIK 0001240122Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 13, 2023Common StockMOption exerciseAcquired+392$2.94+$1,152.48392Direct
Sep 13, 2023Common StockSSaleDisposed−392$32.00−$12,5440Direct
Sep 14, 2023Common StockMOption exerciseAcquired+14,216$2.94+$41,795.0414,216Direct
Sep 14, 2023Common StockSSaleDisposed−14,216$32.00−$454,9120Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 13, 2023Common StockMOption exerciseDisposed−392$0.00$0345,392Direct
Sep 14, 2023Common StockMOption exerciseDisposed−14,216$0.00$0331,176Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)